You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Gynecologic Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 3 | Results 1 - 10 of 22

A Phase 3 Comparison of Platinum-Based Therapy With TSR-042 and Niraparib Versus Standard of Care Platinum-Based Therapy as First-Line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (FIRST)

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Recruiting

A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA
  • Baystate Mary Lane Outpatient Center, 85 South Street, Ware, MA

Active

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (IMagyn050)

Tashanna Myers, MD
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A study to evaluate drug combination therapy in gynecologic cancer

The purpose of this study is to find out if the drug combination of paclitaxel, carboplatin and metformin works better than paclitaxel and carboplatin alone and to find out what side effects are caused by treatment with these drugs.
Tashanna Myers, MD
Cancer-Gynecologic, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active

Comparative Analysis of biomarkers of cervical cells in Human Papillomavirus (HPV) in diagnosis of atypical glandular cells (AGC)

The purpose of this study is to determine whether the presence of human papillomavirus (HPV) and certain chemical substances (biomarkers) in cervical cells can help identify which women with a cytologic diagnosis of AGC have a benign condition and which have a pre-cancerous condition or an invasive cancer that requires surgical removal. (This is a non-treatment study – specimen submission only.)
Tashanna Myers, MD
Cancer, Cancer-Gynecologic
  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Recruiting

Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Tashanna Myers, MD
Cancer-Gynecologic, Cancer

Baystate Medical Center, 759 Chestnut St, Springfield, MA

Active

Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (DART)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA   

Recruiting

Observational study on vulvar cancer

Observational study to investigate the safety of replacing complete inguino femoral lymphadenectomy by adjuvant radiotherapy in early stage vulvar cancer patients with a sentinel node metastasis < or = 2 mm
Tashanna Myers, MD
Cancer, Cancer-Gynecologic

  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active
Page 1 of 3 | Results 1 - 10 of 22